ICON Public Limited Company (ICLR)
ICLR Stock Price Chart
Explore ICON Public Limited Company interactive price chart. Choose custom timeframes to analyze ICLR price movements and trends.
ICLR Company Profile
Discover essential business fundamentals and corporate details for ICON Public Limited Company (ICLR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
15 May 1998
Employees
40.95k
Website
https://www.iconplc.comCEO
Barry Balfe
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICLR Financial Timeline
Browse a chronological timeline of ICON Public Limited Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $2.55, while revenue estimate is $2.00bn.
Earnings released on 23 Jun 2026
EPS came in at $2.50 surpassing the estimated $2.43 by +2.88%, while revenue for the quarter reached $2.03bn , beating expectations by +1.78%.
Earnings released on 27 May 2026
EPS came in at $2.50 falling short of the estimated $3.13 by -20.13%, while revenue for the quarter reached $2.11bn , beating expectations by +6.57%.
Earnings released on 22 Oct 2025
EPS came in at $3.31 surpassing the estimated $3.28 by +0.91%, while revenue for the quarter reached $2.04bn , beating expectations by +3.03%.
Earnings released on 23 Jul 2025
EPS came in at $3.26 surpassing the estimated $3.19 by +2.19%, while revenue for the quarter reached $2.02bn , beating expectations by +1.80%.
Earnings released on 30 Apr 2025
EPS came in at $3.19 surpassing the estimated $3.11 by +2.57%, while revenue for the quarter reached $2.00bn , missing expectations by -0.32%.
Earnings released on 19 Feb 2025
EPS came in at $3.43 surpassing the estimated $3.41 by +0.59%, while revenue for the quarter reached $2.04bn , beating expectations by +0.24%.
Earnings released on 23 Oct 2024
EPS came in at $3.35 falling short of the estimated $3.85 by -12.99%, while revenue for the quarter reached $2.03bn , missing expectations by -4.89%.
Earnings released on 24 Jul 2024
EPS came in at $3.75 surpassing the estimated $3.68 by +1.90%, while revenue for the quarter reached $2.12bn , missing expectations by -0.79%.
Earnings released on 24 Apr 2024
EPS came in at $3.47 surpassing the estimated $3.41 by +1.76%, while revenue for the quarter reached $2.09bn , beating expectations by +0.15%.
Earnings released on 21 Feb 2024
EPS came in at $3.46 surpassing the estimated $3.44 by +0.58%, while revenue for the quarter reached $2.07bn , missing expectations by -1.16%.
Earnings released on 26 Oct 2023
EPS came in at $3.30 surpassing the estimated $3.28 by +0.61%, while revenue for the quarter reached $2.06bn , beating expectations by +0.09%.
Earnings released on 27 Jul 2023
EPS came in at $3.11 surpassing the estimated $3.08 by +0.97%, while revenue for the quarter reached $2.02bn , beating expectations by +0.10%.
Earnings released on 27 Apr 2023
EPS came in at $2.90 surpassing the estimated $2.88 by +0.69%, while revenue for the quarter reached $1.98bn , missing expectations by -0.01%.
Earnings released on 23 Feb 2023
EPS came in at $3.13 surpassing the estimated $3.06 by +2.29%, while revenue for the quarter reached $1.96bn , missing expectations by -0.11%.
Earnings released on 2 Nov 2022
EPS came in at $3.00 surpassing the estimated $2.93 by +2.39%, while revenue for the quarter reached $1.94bn , beating expectations by +0.36%.
Earnings released on 27 Jul 2022
EPS came in at $2.86 surpassing the estimated $2.79 by +2.51%, while revenue for the quarter reached $1.94bn , beating expectations by +0.39%.
Earnings released on 27 Apr 2022
EPS came in at $2.76 surpassing the estimated $2.71 by +1.85%, while revenue for the quarter reached $1.90bn , beating expectations by +0.73%.
Earnings released on 22 Feb 2022
EPS came in at $2.63 matching the estimated $2.63, while revenue for the quarter reached $1.89bn , missing expectations by -0.56%.
Earnings released on 3 Nov 2021
EPS came in at $2.55 surpassing the estimated $2.43 by +4.94%, while revenue for the quarter reached $1.87bn , beating expectations by +5.19%.
Earnings released on 21 Jul 2021
EPS came in at $2.12 surpassing the estimated $2.10 by +0.95%, while revenue for the quarter reached $871.16m , missing expectations by -52.29%.
ICLR Stock Performance
Access detailed ICLR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
